NKTX Nkarta Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NKTX

Price (delayed)

$7.53

Market cap

$372.1M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.4

Enterprise value

$426.66M

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with ...

Highlights
NKTX's EPS is up by 8% year-on-year and by 4% since the previous quarter
Nkarta's net income has increased by 3.9% QoQ but it has decreased by 3.2% YoY
NKTX's quick ratio is down by 33% year-on-year
Nkarta's equity has decreased by 27% YoY and by 8% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.nkartatx.com
Peers: OMER OMGA

Key stats

What are the main financial stats of NKTX
Market
Shares outstanding
49.42M
Market cap
$372.1M
Enterprise value
$426.66M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.35
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$117.5M
EBITDA
-$109.41M
Free cash flow
-$114.31M
Per share
EPS
-$2.4
Free cash flow per share
-$2.33
Book value per share
$5.57
Revenue per share
$0
TBVPS
$7.73
Balance sheet
Total assets
$378.89M
Total liabilities
$105.6M
Debt
$88.34M
Equity
$273.29M
Working capital
$229.74M
Liquidity
Debt to equity
0.32
Current ratio
10.85
Quick ratio
10.76
Net debt/EBITDA
-0.5
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-28.1%
Return on equity
-38.1%
Return on invested capital
-26.6%
Return on capital employed
-33%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NKTX stock price

How has the Nkarta stock price performed over time
Intraday
0.53%
1 week
10.41%
1 month
-23.86%
1 year
50%
YTD
14.09%
QTD
-30.34%

Financial performance

How have Nkarta's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$131.65M
Net income
-$117.5M
Gross margin
N/A
Net margin
N/A
Nkarta's operating income has decreased by 11% YoY but it has increased by 2.8% from the previous quarter
Nkarta's net income has increased by 3.9% QoQ but it has decreased by 3.2% YoY

Growth

What is Nkarta's growth rate over time

Valuation

What is Nkarta stock price valuation
P/E
N/A
P/B
1.35
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NKTX's EPS is up by 8% year-on-year and by 4% since the previous quarter
The P/B is 125% above the last 4 quarters average of 0.6
Nkarta's equity has decreased by 27% YoY and by 8% QoQ

Efficiency

How efficient is Nkarta business performance
NKTX's return on equity is down by 19% year-on-year and by 3.8% since the previous quarter
The ROA has contracted by 10% YoY
NKTX's return on invested capital is down by 3.1% year-on-year

Dividends

What is NKTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NKTX.

Financial health

How did Nkarta financials performed over time
The current ratio has contracted by 34% YoY
NKTX's quick ratio is down by 33% year-on-year
NKTX's debt is 68% smaller than its equity
NKTX's debt to equity is up by 45% year-on-year and by 7% since the previous quarter
Nkarta's equity has decreased by 27% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.